3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelomonocytic, Acute
4
Leukemia, Myeloid, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Erythroblastic, Acute
4
Lymphoma, Non-Hodgkin
3
Wilms Tumor
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Melanoma
2
Medulloblastoma
2
Leukemia, Myelomonocytic, Chronic
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Ependymoma
2
Congenital Abnormalities
2
Breast Neoplasms
2
Brain Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Xanthogranuloma, Juvenile
1
Interventions
Carboplatin
6
Paclitaxel
5
Taxes
3
Docetaxel
3
Cisplatin
3
Gemcitabine
2
Erlotinib Hydrochloride
2
Drug Therapy
2
Bevacizumab
2
talimogene laherparepvec
1
saracatinib
1
romidepsin
1
rilotumumab
1
ganitumab
1
Zoledronic Acid
1
Vinorelbine
1
Tyrosine Kinase Inhibitors
1
Therapeutics
1
Talc
1
Surveys and Questionnaires
1
Spectrum Analysis
1
Sodium Chloride
1
Pemetrexed
1
Nivolumab
1
Metformin
1
Magnetic Resonance Spectroscopy
1
Immunohistochemistry
1
Imatinib Mesylate
1
Gefitinib
1
Fluorodeoxyglucose F18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Pleural Effusion, Malignant
×
tipifarnib
×
Clear all
No trials found.